Medtronic

Delray Beach, Fla. – September 11, 2026 -- The global medical supplies market is projected to grow from $194.76 billion in 2026 to $248.03 billion by 2031, a compound annual growth rate of 7.39%, according to new research from MarketsandMarkets.

Asia Pacific outpaces global growth rate as diagnostic demand accelerates

Asia Pacific is set to register the fastest regional CAGR at 10.2% through 2031, outstripping the global average as healthcare infrastructure expands across the region. By product type, infusion and injectable supplies will grow fastest at a 9.0% CAGR, while diagnostic supplies held the largest share in 2025 and are expected to post the quickest growth of any category over the forecast period, driven by rising chronic and infectious disease burdens and expanding preventive screening programs.

Hong Kong – September 07, 2026 -- Medtronic (NYSE: MDT) will invest approximately $700 million in Hong Kong-based Cornerstone Robotics as part of a strategic alliance granting the U.S. medtech giant distribution rights to the Sentire surgical robotic system in select markets outside the United States where the device is approved.

Medtronic gains distribution rights to Sentire outside the U.S.

The agreement covers markets where Sentire has already secured regulatory clearance, positioning the system alongside Medtronic's existing Hugo robotic surgical platform. Sentire received approval from China's National Medical Products Administration in 2024, followed by CE marking in the European Union and clearance from Singapore's Health Sciences Authority in May 2026 for general, gynecological, thoracic and urological minimally invasive procedures.

SHERIDAN, WYOMING - March 31, 2026 - European hospitals evaluating 2026 imaging, intervention, and workforce plans now have a new validation pathway for AI-assisted neurovascular and oncology procedures as the SHERPA consortium starts seven clinical studies focused on workflow automation, precision support, and staff-pressure reduction in minimally invasive care. The four-year project has a total budget of EUR 21.5 million, is coordinated by Philips, and is co-funded by the EU Innovative Health Initiative and industry partners. Its work targets minimally invasive treatment workflows for brain aneurysms, liver tumors, and lung biopsy settings where specialized expertise is limited and procedure complexity is high.